News

Avenda’s Platform for Personalized Prostate Cancer Mapping Earns FDA Clearance

December 11, 2022

Could an Emerging AI Platform Supplant Traditional MRI for Assessing Prostate Cancer?

December 7, 2022

News, Recognition

Avenda Health Adds Tech Luminary to Board of Directors and Expands Leadership Team

August 26, 2022

News, Recognition

Avenda wins FDA IDE nod for AI-enabled prostate cancer therapy

August 10, 2022

News, Recognition

Exclusive: Avenda gets $10M to advance prostate cancer care

News, Recognition

Avenda Health Granted FDA Breakthrough Device Designation for Technology to Treat Prostate Cancer

News, Recognition

Avenda Health focal laser ablation system wins FDA clearance

December 16, 2020

News, Recognition

Avenda Health Voted “Most Promising Ablative Technology”

October 14, 2020